Literature DB >> 26097614

Epithelioid inflammatory myofibroblastic sarcoma in abdominal cavity: a case report and review of literature.

Hui Wu1, Yu-Hong Meng1, Ping Lu1, Hao-Yong Ning1, Liu Hong1, Xiao-Ling Kang1, Min-Gang Duan1.   

Abstract

In this study, we present a rare and difficult case of epithelioid inflammatory myofibroblastic sarcoma (EIMS) in abdominal cavity. A 47-year-old female presented as left upper abdominal pain for 6 months and abdominal distention for 1 month. CT examination showed a solid mass in the left upper intra-abdomen. Grossly, the tumor was found in the mesenterium of colon with the size of 7.5 × 6.5 × 3.5 cm, and was solid and gray-yellowish in the cut surface. Focal myxomatous appearance was observed. Microscopically, stromal myxoid change together with prominant infiltrated lymphocytes, neutrophils and eosinophils were found in the tumor, and the tumor cells were round, epithelioid with vesicular nuclei, large prominant nucleoli and high mitotic rate. Immunohistochemically, strong diffused positive for vimentin, desmin, ALK (nuclear membrane staining pattern) and AAT, focally positive for CD99 and CD30, were showed, Ki67 index was about 20%; Especially, WT-1 and D240 were focally expressed in this tumor. FISH analysis showed rearrangement of ALK, and reverse-transcription polymerase chain reaction (RT-PCR) analysis was used to detect the fusion location of the RANBP2 and ALK gene. The diagnosis of EMIS was made based on its location, typical morphology, the immunohistochemical features especially the nuclear membranous immunostaining of ALK and rearrangement of RANBP2-ALK. The tumor showed higher aggressive behaviors and a poor prognosis. The differential diagnosis and other treatments of EMIS are also discussed in the present study. This finding may increase the case information of EMIS.

Entities:  

Keywords:  ALK; Epithelioid inflammatory myofibroblastic sarcoma; retroperitoneal

Mesh:

Substances:

Year:  2015        PMID: 26097614      PMCID: PMC4467001     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  12 in total

1.  Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study.

Authors:  J R Cook; L P Dehner; M H Collins; Z Ma; S W Morris; C M Coffin; D A Hill
Journal:  Am J Surg Pathol       Date:  2001-11       Impact factor: 6.394

2.  Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.

Authors:  Adrián Mariño-Enríquez; Wei-Lien Wang; Angshumoy Roy; Dolores Lopez-Terrada; Alexander J F Lazar; Christopher D M Fletcher; Cheryl M Coffin; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2011-01       Impact factor: 6.394

3.  Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.

Authors:  Zhigui Ma; D Ashley Hill; Margaret H Collins; Stephan W Morris; Janos Sumegi; Ming Zhou; Craig Zuppan; Julia A Bridge
Journal:  Genes Chromosomes Cancer       Date:  2003-05       Impact factor: 5.006

4.  ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor.

Authors:  Maria Debiec-Rychter; Peter Marynen; Anne Hagemeijer; Patrick Pauwels
Journal:  Genes Chromosomes Cancer       Date:  2003-10       Impact factor: 5.006

5.  Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.

Authors:  Hongbo Yu; Joanna A Gibson; Geraldine S Pinkus; Jason L Hornick
Journal:  Am J Clin Pathol       Date:  2007-11       Impact factor: 2.493

6.  An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features.

Authors:  Sung-Ting Chen; Jen-Chieh Lee
Journal:  Hum Pathol       Date:  2008-08-12       Impact factor: 3.466

7.  Epithelioid inflammatory myofibroblastic sarcoma arising in the pleural cavity.

Authors:  Yoshiki Kozu; Mitsuhiro Isaka; Yasuhisa Ohde; Kengo Takeuchi; Takashi Nakajima
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-01-24

8.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

9.  RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors.

Authors:  Ankita S Patel; Kathleen M Murphy; Anita L Hawkins; Julie S Cohen; Patricia P Long; Elizabeth J Perlman; Constance A Griffin
Journal:  Cancer Genet Cytogenet       Date:  2007-07-15

10.  Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.

Authors:  Jan Cools; Iwona Wlodarska; Riet Somers; Nicole Mentens; Florence Pedeutour; Brigitte Maes; Christiane De Wolf-Peeters; Patrick Pauwels; Anne Hagemeijer; Peter Marynen
Journal:  Genes Chromosomes Cancer       Date:  2002-08       Impact factor: 5.006

View more
  7 in total

1.  Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.

Authors:  Xuemei Du; Ying Gao; Hongyu Zhao; Bin Li; Weimin Xue; Daye Wang
Journal:  Oncol Lett       Date:  2018-04-18       Impact factor: 2.967

Review 2.  Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature.

Authors:  Shefali Chopra; Nolan Maloney; Wei Lien Wang
Journal:  Brain Tumor Pathol       Date:  2021-11-06       Impact factor: 3.298

Review 3.  Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.

Authors:  Qiuyu Liu; Yunzhen Kan; Yuewu Zhao; Hui He; Lingfei Kong
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

4.  Metastatic Anaplastic Lymphoma Kinase-1 (ALK-1)-Rearranged Inflammatory Myofibroblastic Sarcoma to the Brain with Leptomeningeal Involvement: Favorable Response to Serial ALK Inhibitors: A Case Report.

Authors:  Cai Yuan; Muchou J Ma; John V Parker; Tarek M Mekhail
Journal:  Am J Case Rep       Date:  2017-07-17

5.  CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma.

Authors:  Karen L MacKenzie; Toby N Trahair; Ashleigh M Fordham; Jinhan Xie; Andrew J Gifford; Carol Wadham; Lisa T Morgan; Emily V A Mould; Mitali Fadia; Lei Zhai; Hassina Massudi; Zara S Ali; Glenn M Marshall; Robyn E Lukeis; Jamie I Fletcher
Journal:  Br J Cancer       Date:  2020-07-20       Impact factor: 7.640

Review 6.  Inflammatory Myofibroblastic Tumour: State of the Art.

Authors:  Louis Gros; Angelo Paolo Dei Tos; Robin L Jones; Antonia Digklia
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

7.  Incomplete Intestinal Obstruction Caused by a Rare Epithelioid Inflammatory Myofibroblastic Sarcoma of the Colon: A Case Report.

Authors:  Yanjun Bai; Maofen Jiang; Wenjie Liang; Feng Chen
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.